成骨细胞
骨质疏松症
去卵巢大鼠
内分泌学
内科学
过氧化物酶体增殖物激活受体
脂肪生成
癌症研究
体内
化学
生物
医学
体外
雌激素
受体
脂肪组织
生物化学
遗传学
作者
Liangjie Lu,Lijun Wang,Jiqiong Wu,Minjie Yang,Binhui Chen,Huihan Wang,Kaifeng Gan
出处
期刊:Epigenomics
[Future Medicine]
日期:2022-06-01
卷期号:14 (12): 777-792
被引量:11
标识
DOI:10.2217/epi-2021-0391
摘要
Background: This study was designed to elucidate the role of DNMT3a and PPARγ functions in postmenopausal osteoporosis. Materials & methods: Mice were ovariectomized to establish an in vivo osteoporosis model and MC3T3-E1-14 osteoblasts were induced to differentiate. Gain- or loss-of-function approaches were used to manipulate the expression of PPARγ, DNMT3a and SCD1, followed by an evaluation of their role in postmenopausal osteoporosis both in vivo and in vitro. Results:DNMT3a induced methylation of the PPARγ promoter region, consequently stimulating osteoblast differentiation. PPARγ elevated SCD1, which decreased GLUT1 and inhibited osteoblast differentiation. Inhibition of PPARγ reduced SCD1 while increasing GLUT1 expression, thus alleviating postmenopausal osteoporosis in mice. Conclusion:DNMT3a promotes osteoblast differentiation and prevents postmenopausal osteoporosis by regulating the PPARγ/SCD1/GLUT1 axis.
科研通智能强力驱动
Strongly Powered by AbleSci AI